(123)i-meta-iodobenzylguanidine
(123)i-mibg
1-alkyl-2-acetyl-sn-glycerol cholinephosphotransferase
2-vessel cad
2-way anova
3-vessel cad
6 min walk test
6-min walk test
6-minute hall walk
6-minute walk distance
6-minute walk test
6-minute walked distance
6-minute walking distance
6-mwt
6mwt
8-fluo-camp
a comparison of outcomes in patients in new york heart association [nyha] class ii heart failure when treated with eplerenone or placebo in addition to standard heart failure medicines
abcc2
abcd classification
absorptiometry
acetylcholinesterase inhibitor
acute
acute ischemic right heart failure
acute right heart failure
adenoviral
adjusted odds ratio
adjuvant
adrenergic
adrenomedullin
adverse event
adverse events
adverse outcome
adverse outcomes
aetiologies
akt→forkhead box class o-1 signaling
aldactone
aldosterone receptor
all-cause hospitalisations
all-cause hospitalization
all-cause hospitalizations
all-cause readmissions
allogeneic
ambulatory
amino-terminal pro-b-type natriuretic peptide
amyloidotic
anabolic
anastomosis
anemic
anesthetized
ang ii
angeli's salt
angiotensin
angiotensin converting enzyme
angiotensin ii  infusion
angiotensin receptor antagonist
angiotensin receptor neprilysin inhibitor
angiotensin-converting enzyme
ann arbor veterans' affairs
annular ms
antagonism
antagonist
anterior leaflet
anti-inflammatory
antiadrenergic
antiarrhythmic
antitumor
aortic
aortic insufficiency
aortic pressure
apex
area under the curve
area under the receiver operating characteristic curve
arg16/gln27
arg76
arterial
arteries
artery
artery tonometry
arthritis
asymptomatic
at
at1
atherosclerotic
atpase
atrioventricular
atrium
autologous
autonomic nervous system
b natriuretic peptides
b-type natriuretic peptides
b-type np
baroreflex
baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction
barriers to exercise score
benign tumors
bioprosthetic aortic valve replacement
bioprosthetic valve replacement
biopsies
biopsy
biventricular support
blood
blood cell
blood flow
blood glucose
blood-flow
bolus
bone morphogenetic protein 4
bradycardia
brain
brd4
breathing
bromodomain
btt
bundle branch morphology
bypass
c statistic
c statistics
c termini
c-kit+ cell
c-kit+ cells
c-kit+ progenitors
c-statistics
c-terminally
ca(2+)
ca(2+) handling
ca(2+) sensitivity
ca2(+)
ca2+
calcium-sensitizing agents
california office of statewide health planning and development patient discharge data nonpublic file
camp signaling
candesartan
carcinoma
cardiac defibrillator
cardiac energy metabolism gene expression
cardiac growth
cardiac magnetic resonance postcontrast t1 time
cardiac metabolic gene expression
cardiac sodium
cardiac transplants
cardiac vegf expression
cardiac volume
cardiac volume overload
cardiogenic
cardiography
cardiology-cardiovascular surgery consensus report
cardiomyiopathy
cardiomyocyte
cardioprotective signaling
cardiopulmonary exercise test
cardiovascular event
cardiovascular outcomes in renal atherosclerotic lesions
carotid intima-media thickness
caspase 3
catecholamine
catecholamines
catheter
catheterisation
cd133+ cells
cd34+vegfr2+ cells
cell death
cellular metabolism
cellular plasticity
central glycosylated region
centre for reviews and dissemination
cerebral
cerebrovascular
cgmp synthesis
ch
chagas' disease
chamber
charm
cha₂ds₂vasc score
chelation
chest
chromatin structure
chromatin subproteome
chronic hfpef
chronic pah
chronotropic response
ci
cinahl
circulatory support
circumferential strain
circumflex artery
clcnka
clinical
clinical practice guidelines
clinically
clinician
clinicians
clinics
cluster analysis
co-morbidities
co-morbidity
co-primary outcome
cochrane effective practice and organisation of care taxonomy
cohort studies
cohort study
collagen
collagen cross-linking
combined end point
comorbid
comorbidity
compensated hfpef
compensated lv hypertrophy
complication
composite end point
composite end-point
composite primary outcome
congenital
connecticut
consultations
contemporaneous control group
continuity equation
continuous flow
continuous wave doppler echocardiography
contractile response
contracting
coprimary outcome
coronary
coronary artery
coronary artery bypass
correlate
correlated
correlates
correlation
correlation coefficient
correlations
covariate
covariate adjustment
covariates
cox modeling
cox proportional hazard analyses
cox proportional hazard models
cox proportional hazards analyses
cox proportional hazards models
cox proportional hazards regression modeling
cox regression analysis
cpcs
creatine
cri
cronbach's α
crossover study
cs
curative
cyclase
cyclic adenosine monophosphate
cyclic guanosine monophosphate
cystatin c
cytochrome c
cytoskeleton
cytotoxic
cα
dapc protein
dash/srd
dd
deaths
decompensated heart failure
decompensated hf
decompensated systolic heart failure
decompensation
defibrillation
defibrillators
degenerative mitral regurgitation
degenerative mitral valve
degenerative mr
denervation
descriptive statistics
destination therapy
dhand
diastolic filling formalism
diastolic filling time
diastolic mitral annulus velocity
diastolic mitral leaflet motions
diastolic stiffness
dietary approaches to stop hypertension
differential analysis
differential effect
differentially expressed genes
dilatation
dilated lv
dilation
discharges
diseased
diseases
donors
double-blind
downregulated
downregulation
downstream signaling
downstream signalling
dpp-4
dual energy x-ray absorptiometry
dysfunction
e/e'
early treatment of atrial fibrillation for stroke prevention trial
ec
echo-derived pulmonary arterial systolic pressure
ecs
edema
effector molecules
electrocardiogram
electrocardiographic q waves
embolectomy
embolism
embolize
emergency room
end point
end points
end-point
end-stage hf
end-stage renal disease
end-systolic
endopeptidase
endopeptidase inhibitors
endothelial
endpoint
endpoints
enos-ser(1177)
enos-thr(495)
enzyme
enzymes
ephesus
epidemic
eplerenone post myocardial infarction heart failure efficacy and survival study
erk1/2
erythropoiesis
erythropoiesis-stimulating agent
estimated glomerular filtration rate
ethics rounds
evidence based practice centres
exercise tolerance
exercise-induced pulmonary artery systolic pressure
explant
explants
exploratory factor analysis
expressions
extended criteria cardiac transplant
extended criteria cardiac transplantation
extra corporeal membrane oxygenation
extracellular
extracorporeal life support
extracorporeal support
fat-free mass
ffm
fibrillation
fluid retention
fluorescence resonance energy transfer
follow-up duration
followed up
followed-up
fractional flow reserve
fractional shortening
free wall cs
free wall rs
fully magnetically levitated centrifugal-flow chronic lvas
fully magnetically levitated left ventricular assist system
fully magnetically levitated lvas
functional enrichment analysis
functional status
g-protein coupling
g-protein-coupled receptor
gadolinium-chelate
gata4
gdmt
gem/kir
gene
gene induction
general anaesthesia
genomic
genotype
genotyped
get with the guidelines-heart failure
global gene expression
global left ventricular longitudinal systolic strain
glucocorticoid
glucocorticoids
glucose
gly16/glu27
gly4
gly7
grade 4/6 holosystolic murmur
grading of recommendations assessment, development and evaluation
gtpase
haematopoietic
health abc hf model
health abc hf risk model
health-care
healthcare common procedure coding system codes
heart  failure
heart failure - a controlled trial investigating outcomes in exercise training
heart failure and reduced ejection fraction
heart failure with a reduced ejection fraction
heart failure with preserved ejection fraction
heart failure with preserved left ventricular ejection fraction
heart failure with reduced ejection fraction
heart failure: a controlled trial investigating outcomes of exercise training
heart muscle
heart sound
heart-specific irs1 and irs2 gene double-knockout
hemocompatibility
hemodynamic phenotype
hepatic
heterochromatic chromatin
hf index
hf with preserved ef
hf with preserved ejection fraction
hf with reduced ef
hf with reduced ejection fraction
hf-ref
hhd
histologically
hm ii
homozygous
hospital compare
hospitalisation
hospitalisations
hrv
human embryonic kidney
human induced pluripotent stem cell-derived cardiomyocytes
human-to-human contact
human-to-machine interface
hypertensive heart failure with preserved ejection fraction
hypertensive hfpef
hypertrophic
hypertrophied
hypothermic circulatory arrest
ic
icds
idiopathic
idiopathic-dilated cardiomyopathy
implantable cardiac arrhythmia devices
implantable cardioverter defibrillator
implants
in vitro
in vivo
in vivo coronary perfusion
incremental shuttle walk test
infarction
inferior vena cava
infusions
ingenuity pathway analysis
inhospital
injections
inoperable
insignificantly
insulin receptor substrates 1
integrated discrimination improvement
intensive care
intensive care unit
intention-to-treat
interaction term analysis
interatrial
interatrial shunt
interatrial shunting
international right heart foundation working group
interventricular
interventricular septum
intestinal
intracellular
intravenous
intravenous bolus
intravenously
intubation
invasive
invasive haemodynamic assessment
invasively
inverse correlation
ischaemia
ischemic hf
ischemic mr
isoelectric focusing
isoforms
isolated coronary artery bypass grafting
ivc
joanna briggs institute
joanna briggs institute evidence based practice
jugular
ka renal chloride channel gene
kaiser permanente
kidney disease
kinase
kinase-2
l-type ca2(+) current
l-type channel
l-type currents
l-type voltage-gated ca(2+) channels
lactate
lbbb
leaflet
lean mass quantification
left anterior descending artery
left atrial
left atrium
left bundle-branch block
left heart twist
left ventricle end-diastolic pressure
left ventricular dd
left ventricular ejection time
left ventricular end-diastolic pressure
left ventricular function
left ventricular hypertrophy
lesion
lesions
leu3
life expectancy
likelihood ratio
linear mixed models
linear models
lipid
liver
liver-specific irs1 and irs2 double-knockout
log rank
longitudinal
lv assist device
lv assist device implantation
lv assist device implantations
lv compliance
lv contractile function
lv contractility
lv diastolic dysfunction
lv ef
lv ejection fraction
lv end-diastolic dimension
lv end-diastolic pressure
lv end-diastolic volume
lv end-systolic volume
lv filling pressure
lv fractional shortening
lv function
lv internal diameter
lv mass
lv posterior wall
lv relaxation
lv remodeling
lv strain
lv strain rate
lvad therapy
madit-crt
magnet
mapk
mass spectrometric analysis
massive embolism
maximal ventricular power index
maximum oxygen consumption
mechanical cardiac support
mechanical circulatory support
medicaid
medical history
medical outcomes study short-form
medical treatment
medically
medicines
mena deletion
mesenchymal
meta-analyses
meta-analysis
meta-analyzed
mets
michigan
microarray
microembolization
mild heart failure
mild hf
minimal detectable change
minnesota quality of life
mitochondrial complex v activity
mitochondrial structure
mitogen-activated protein kinase
mitral annular velocity
mitral annulus velocity
mitral leaflet motions
mixed linear models
mixed models
mixed-methods study
mlhf questionnaire
morbidities
morpholino-based
mpsms
mr-proanp
mri scanner
multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy
multicenter automatic defibrillator implantation with cardiac resynchronization therapy
multivariable adjustment
multivariable analysis
multivariable logistic analysis
multivariable models
multivariable regression
multivariate analyses
multivariate analysis
multivariate cox proportional hazards regression modeling
multivariate cox regression analyses
multivariate logistic regression analysis
multivariate model
multivariate models
multivariate regression
multivariate-adjusted odds ratio
muscle
muscles
muscular
myocardial dd
myocardial oxygen consumption
myoctyes
myocyte-specific mena overexpression
myosin
myxoma
n-terminal pro-b-type natriuretic peptide
n-terminal pro-b-type natriuretic peptides
n-terminal pro-b-type np
n-terminal pro-brain-type natriuretic peptide
n-terminal probnp
n2bus
na+ channel
na+ channel α-subunit
na+ channels
nad(p)h-oxidase
nanog
nanomolar
narrow qrs complex
national cardiovascular disease registry practice innovation and clinical excellence registry
natriuretic
negative binomial regression models
neprilysin
net-reclassification-improvement
neuro-hormonal
neurohormonal systems
neurohormonally
neurohumoral
new york heart association class
new york heart association class i
new york heart association class ii
new york heart association class iii
new york heart association classes
new york heart association classification
new york heart association functional class
nf-κb
nfat
no
non-biological disease modifying antirheumatic drug
non-cachectic chf
non-dilated left ventricle
non-invasively
non-ischemic heart failure
noncardiovascular
noninvasive
nonischemic
nonischemic cardiomyopathies
nonmitochondrial
nonmitochondrial protein
nonselective β-blocker
nonsignificant
nontrastuzumab users
northern california
nosignificant
nri
nt-pro bnp
nuclear factor of activated t cells
nurse practitioner
nursing
nyha class
nyha class iii
nyha class iiib
nyha classification
nyha functional class
nyha functional class ii
nyha functional class iii
nyha functional class iv
nyha-ii
nyha-iii
nyha-iiib
observational cohort studies
observational cohort study
oedema
ontario
operative
or
oral
orally
organ
organ failure
organic
out-patient
outcomes
p value
p values
p-value
p.arg83gly
p3 prolapse
p38
p38alpha
p38α
p70s6k-ser(411)
pacing-induced chf
palliative care
parasympathetic
partial pressure of end-tidal co2
pathobiology
pathological
pathology
pathophysiologic
pathophysiologically
patient
patients
paucity
pde
pdrelated
peak early diastolic mitral annular velocity
peak o2
peak respiratory quotient
pediatric fontan
peptide
peptides
perceived social support score
percutaneous
periodic breathing
perioperative
peripheral edema
peripheral muscle
perk
pharmaceutically
pharmaceuticals
phenotype
phenotypes
phosphomimic
physical examination
physical therapy
physio ring 30
physiologic
physiological
physiology
pkc-βii-ser(660)
placebo
plasma b-type natriuretic peptide
plasma n-terminal pro-b-type natriuretic peptide
plasma norepinephrine
pluripotency marker
pluripotency markers
point of care
point-of-care
polymerase ii
polymorphism
polytetrafluoroethylene
post hoc analysis
post-lvad ai
postcontrast t1
postoperatively
power spectral analysis
preoperative
prescribed
prescribing
prescription
preserved ef
preserved left ventricular ejection fraction
preserved left ventricular ejection fractions
preserved lv ejection fraction
preserved lvef
pressure volume relation
prevalence
primary composite endpoint
primary outcomes
pro bnp
pro-b-type natriuretic peptide
pro-b-type natriuretic peptides
pro-b-type np
pro-brain natriuretic peptide
pro2
pro6
pro75
proangiogenic
proanp
probnp
prodrug
progenitor
progenitor cells
progenitors
prognosis
prognostically
proof-of-principle cohort study
propensity-score
prospective
prospective studies
prospective study
prospectively
protein kinase a
protein kinase r-like er kinase
protein-c
proteolysis
proteomic
psychometric
psychosocial
pulmonary
pulse
pulse-wave
q66p
qrs complex
qrs duration
qrs prolongation
qt interval
québec health insurance board
r-r interval
rac1
rac2
raf-mek1/2-erk1/2 signalling pathway
random-effects models
randomised
randomised-controlled trials
randomization
randomize
randomized
ras-blocker
re-hospitalization
receptor
red blood cell
redo sternotomy
reduced ef
reduced ejection fraction
reduced left ventricular ejection fraction
refractory right heart failure
regression analyses
regression analysis
regression line
regression modeling
regression models
rehabilitation
remodelling
renal optimization strategies evaluation
renin
renin inhibitors
reoperation
reperfusion
repolarization
respiratory gas analysis
resting hemodynamics
resuscitation
resynchronization
resynchronization reverses remodeling in systolic left ventricular dysfunction
resynchronization therapy
resynchronization-defibrillation for ambulatory heart failure trial
retrospective cohort
retrospective cohort study
retrospective matched cohort study
revascularization
reverse
rgk
rheumatoid
rhythm control
right atrial
right heart filling pressures
right pulmonary artery
right ventricular assist devices
right ventricular contractile function
right ventricular end-diastolic area index
right ventricular fractional area
right ventricular support
rna
rnas
rotterdam study
rr
rs10927887
rtq-pcr
rv decompensation
rv support
rvad
s'
s12884
s1pr1 agonist
s3991
sarcopenic range muscle wasting
scaffold protein
scaffold proteins
schfi v.6.2
sd of all qt intervals
sd of rr intervals
sdrr
seattle heart failure model
second-generation sulfonylureas
secondary end point
secondary end points
secondary endpoints
secondary outcomes
selective beta-blockers
selective β-blocker
self-care of heart failure index version 6.2
ser96
serum albumin
serum sodium
severe heart failure
severe hf
severe systolic heart failure
short-term fractal scaling exponent
shotgun lc-ms/ms
shunt
shunting
shunts
signal transduction
signaling pathway
signaling pathways
signalling pathway
signalling pathways
signalling proteins
signalosome complex
significance
significant
significantly
smad 2/3
spearman correlations
specificity
sphingosine-1-phosphate receptor 1
spontaneous ventricular tachycardia
spontaneous vt
sr ca(2+)-pump
st-segment-elevation mis
stable
stable hf
standard error of measurement
stenosis
stenotic physiology
sternal
stress doppler echocardiography
stroke volume index
structured telephone support
student t test
subclinical
subproteome
subproteomes
subvalvular
surgeons
surgical palliation
surgically
svr
sympathetic control of heart rate
symptom
symptomatic
symptomatic adult fontan
symptomatic chronic advanced heart failure
symptomatic systolic heart failure
symptoms
syndrome
syndromes
systemic
systemic blood pressure
systolic  heart failure
systolic heart failure treatment with the if inhibitor ivabradine trial
systolic left ventricular dysfunction
systolic volume index
t1
t1 mapping
t1 time
t1 times
t1-mapping
t2*
tachyarrhythmias
tachycardic
telemonitoring
terminal
testosterone supplementation
testosterone therapy
texas
texas cancer registry–medicare
tgf-β receptor type i
thalassaemia major
the chronic kidney disease epidemiology collaboration
the danish heart failure database
the lancet
therapeutic
therapeutics
therapies
third heart sound
thr197
thromboembolic
thromboembolic pulmonary hypertension
thromboembolism
thrombotic
timed up & go
timed up & go test
tissue doppler
titrated
tm24/7
tonometric
tonometry
tools for economic analysis of patient management interventions in heart failure cost-effectiveness model
total arterial compliance
transcatheter aortic valve procedure
transient receptor potential cation channel m7
transmitral blood flow velocity
transoesophageal echocardiographic
transplantations
transseptal
trichrome blue histologic analysis
tricuspid
tricuspid annular plane
troponin i
troponin t
trpm7
tta/tgtetmena
tumor
tumors
type i regulatory subunit
u.s. food and drug administration's mini-sentinel
ulcers
undiagnosed
unilateral renal denervation
univariable analysis
univariate analysis
university of connecticut heart failure center
uptitration
uptitrations
us
use of exercise and medical therapies to improve cardiac function among patients with exertional shortness of breath due to lung congestion
vascular
vascular disease
vasodilator
vasodilatory
vasopressin type 2 receptor antagonist
vegf pathway
vegf receptor
vegf signaling pathway
ven/vco2 slope
venous
ventricle
ventricles
ventricular fibrillation
ventricular function
ventricular myocytes
ventricular systolic hf
ventricularly
video edge detection
vo2 max
wall stiffness
wide qrs complex
wilcoxon matched-pairs signed-rank tests
wistar-kyoto
women's health initiative
x-ray
xo-mediated ros
yorkshire
z-score
zung self-rated depression scores
β coefficient
β-adrenergic receptor
β-adrenergic receptor blocker
β-ar
β-ar responsiveness
β1ar
